Have a personal or library account? Click to login
Survival of node-negative breast cancer patients treated at the university medical centre Maribor in the period 2000–2009 Cover

Survival of node-negative breast cancer patients treated at the university medical centre Maribor in the period 2000–2009

Open Access
|May 2017

References

  1. Zadnik V, Primic Žakelj M. SLORA: Slovenija in rak. Epidemiologija in register raka. Onkološki inštitut Ljubljana. Available Mar 25, 2017 from: www.slora.si.
  2. Cancer in Slovenia 2013. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2016.
  3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-403.
  4. Amaro J, Severo M, Vilela S, Fonseca S, Fontes F, La Vecchia C et al. Patterns of breast cancer mortality trends in Europe. Breast 2013; 22: 244-53.
  5. Zadnik V, Žagar T, Žakelj MP. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdr Varst 2016; 55: 134-41.
  6. Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol 2014; 45: 1785-92.
  7. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
  8. Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S et al. Benefits and harms of breast cancer screening: s systematic review. JAMA 2015; 314: 1615-34.
  9. Lousdal ML, Kristiansen IS, Møller B, Støvring H. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Eur J Public Health 2014; 24: 1017-22.
  10. Anon. DORA v letu 2016 izpolnila vse zastavljene cilje širitve. Available Mar 25, 2017 from: http://dora.onko-i.si/novice/novica/article/142/index.html?cHash=d525be78f0fef15ce00576373dde5a8d.
  11. Cancer incidence in Slovenia 2001. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2004.
  12. Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2013.
  13. Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O et al. Effects of screening and systemic adjuvant therapy on ERspecific US breast cancer mortality. J Natl Cancer Inst 2014; 106: dju289.
  14. Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M et al. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer 2015; 51: 2191-205.
  15. Cancer in Slovenia 2009. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2013.
  16. Imkampe AK, Bates T. Improvements in breast cancer survival over time, related to adjuvant treatment and node status. Eur J Surg Oncol 2009; 35: 151-5.
  17. Taib NA, Akmal M, Mohamed I, Yip CH. Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, Malaysia. Asian Pac J Cancer Prev 2011; 12: 345-9.
  18. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378: 1707-16.
  19. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-717.
  20. Roder DM, de Silva P, Zorbas HM, Kollias J, Malycha PL, Pyke CM et al. Age effects on survival from early breast cancer in clinical settings in Australia. ANZ J Surg 2012; 82: 524-8.
  21. Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 2010; 28: 2868-73.
  22. Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H et al. Breast cancer survival in the US and Europe: a CONCORD highresolution study. Int J Cancer 2013; 132: 1170-81.
  23. Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J 2015; 19: 48-79.
DOI: https://doi.org/10.1515/sjph-2017-0025 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 185 - 192
Submitted on: May 21, 2016
|
Accepted on: Apr 21, 2017
|
Published on: May 26, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Nina Fokter Dovnik, Darja Arko, Nina Čas Sikošek, Iztok Takač, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.